PT  - JOURNAL ARTICLE
AU  - Sinclair, Heather Q.
ED  - Patkar, Ashwin
TI  - Ziprasidone Therapy in the Acute Depressive Mixed State
DP  - 2010 Aug 01
TA  - MD Conference Express
PG  - 11--11
VI  - 10
IP  - 4
4099  - http://mdc.sagepub.com/content/10/4/11.short
4100  - http://mdc.sagepub.com/content/10/4/11.full
AB  - Ziprasidone demonstrated efficacy and tolerability among patients with depressive mixed state, according to a recent study. In this double-blind, placebo-controlled, multicenter trial that included 74 patients who met DSM-IV criteria for major depressive disorder and two to three DSM-IV mania criteria, patients were randomized to receive either ziprasidone 40–160 mg/daily (n=36) or placebo (n=38) for 6 weeks in a forced titration regimen.